Skip to main content

Red yeast rice Disease Interactions

There is 1 disease interaction with red yeast rice.

Moderate

HMG-CoA reductase inhibitors (applies to red yeast rice) renal disease

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction

Some HMG-CoA reductase inhibitors (e.g., fluvastatin) have not been studied in patients with severe renal dysfunction or end-stage renal disease. Some others (e.g., pitavastatin, simvastatin) require a dose reduction when used in this group of patients. Caution and close monitoring are advised when using these drugs in patients with renal dysfunction.

References (8)
  1. (2002) "Product Information. Mevacor (lovastatin)." Merck & Co., Inc
  2. (2001) "Product Information. Pravachol (pravastatin)." Bristol-Myers Squibb
  3. (2001) "Product Information. Zocor (simvastatin)." Merck & Co., Inc
  4. (2001) "Product Information. Lescol (fluvastatin)." Novartis Pharmaceuticals
  5. (2003) "Product Information. Crestor (rosuvastatin)." AstraZeneca Pharma Inc
  6. (2010) "Product Information. Livalo (pitavastatin)." Kowa Pharmaceuticals America (formerly ProEthic)
  7. (2024) "Product Information. Lipitor (atorvastatin)." Viatris Specialty LLC, SUPPL-81
  8. (2024) "Product Information. Atorvaliq (atorvastatin)." Carolina Medical Products Company, SUPPL-2

Switch to consumer interaction data

Red yeast rice drug interactions

There are 289 drug interactions with red yeast rice.

Red yeast rice alcohol/food interactions

There are 2 alcohol/food interactions with red yeast rice.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer